Opposite contributions of trunk and leg fat mass with plasma lipase activities: The hoorn study

Obesity Research

Volumn 13, Issue 10, 2005, Pages 1817-1823

  Bos, Griët ^a,b   Snijder, Marieke B ^a   Nijpels, Giel ^a   Dekker, Jacqueline M ^a   Stehouwer, Coen D A ^a,c   Bouter, Lex M ^a   Heine, Robert J ^a,c   Jansen, Hans ^d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

DXA; Femoral fat; Intra abdominal fat; Lipase activity

Indexed keywords

LIPID; TRIACYLGLYCEROL LIPASE;

ABDOMINAL FAT; AGED; ARTICLE; BLOOD; ENZYMOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; LEG; LIVER; MALE; MIDDLE AGED; OBESITY; ORGAN SIZE; RADIODENSITOMETRY;

ABDOMINAL FAT; ADIPOSITY; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DENSITOMETRY, X-RAY; FEMALE; GENOTYPE; GLUCOSE TOLERANCE TEST; HUMANS; LEG; LIPASE; LIPIDS; LIVER; MALE; MIDDLE AGED; ORGAN SIZE; POLYMORPHISM, GENETIC;

EID: 33644807327     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2005.221     Document Type: Article

References (31)

1. de Vegt F, Dekker JM, Jager A, et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn study. JAMA. 2001;285:2109-13.
2. Björntorp P. Metabolic implications of body fat distribution. Diabetes Care. 1991;14:1132-43.
3. Kelley DE, Williams KV, Price JC, McKolanis TM, Goodpaster BH, Thaete FL. Plasma fatty acids, adiposity, and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2001;86:5412-9.
4. Clausen JO, Borch-Johnsen K, Ibsen H, et al. Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest. 1996;98:1195-209.
5. Van Pelt RE, Evans EM, Schechtman KB, Ehsani AA, Kohrt WM. Contributions of total and regional fat mass to risk for cardiovascular disease in older women. Am J Physiol Endocrinol Metab. 2002;282:E1023-8.
6. Snijder MB, Dekker JM, Visser M, et al. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. Diabetes Care. 2004;27:372-7.
7. Carr MC, Hokanson JE, Zambon A, et al. The contribution of intra-abdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity. J Clin Endocrinol Metab. 2001;86:2831-7.
8. Despres JP, Couillard C, Gagnon J, et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol. 2000;20:1932-8.
9. Yang T, Pang CP, Tsang MW, et al. Pathogenic mutations of the lipoprotein lipase gene in Chinese patients with hypertriglyceridemic type 2 diabetes. Hum Mutat. 2003;21:453.
10. Rebuffe-Scrive M, Enk L, Crona N, et al. Fat cell metabolism in different regions in women. Effect of menstrual cycle, pregnancy, and lactation. J Clin Invest. 1985;75:1973-6.
11. Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med. 1995;27:435-8.
12. Frayn KN. Adipose tissue as a buffer for daily lipid flux. Diabetologia. 2002;45:1201-10.
13. Bergeron J, Couillard C, Despres JP, et al. Race differences in the response of post-heparin plasma lipoprotein lipase and hepatic lipase activities to endurance exercise training in men: results from the HERITAGE Family Study. Atherosclerosis. 2001;159:399-406.
14. Berk-Planken II, Hoogerbrugge N, Stolk RP, Bootsma AH, Jansen H. Atorvastatin dose-dependently decreases hepatic lipase activity in type 2 diabetes: effect of sex and the LIPC promoter variant. Diabetes Care. 2003;26:427-32.
15. Frenais R, Nazih H, Ouguerram K, et al. In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus. J Clin Endocrinol Metab. 2001;86:1962-7.
16. Mooy JM, Grootenhuis PA, de Vries H, et al. Prevalence and determinants of glucose intolerance in a Dutch Caucasian population. The Hoorn Study. Diabetes Care. 1995;18:1270-3.
17. Jansen H, Hop W, van Tol A, Bruschke AV, Birkenhager JC. Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease. Atherosclerosis. 1994;107:45-54.
18. Alberti KG, Zinimet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med. 1998;15:539-53.
19. Duncan GE, Perri MG, Theriaque DW, Hutson AD, Eckel RH, Stacpoole PW. Exercise training, without weight loss, increases insulin sensitivity and post-heparin plasma lipase activity in previously sedentary adults. Diabetes Care. 2003;26:557-62.
20. Purnell JQ, Kahn SE, Albers JJ, Nevin DN, Brunzell JD, Schwartz RS. Effect of weight loss with reduction of intraabdominal fat on lipid metabolism in older men. J Clin Endocrinol Metab. 2000;85:977-82.
21. Despres JP, Ferland M, Moorjani S, et al. Role of hepatictriglyceride lipase activity in the association between intraabdominal fat and plasma HDL cholesterol in obese women. Arteriosclerosis. 1989:9:485-92.
22. Sibley SD, Palmer JP, Hirsch IB, Brunzell JD. Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes. J Clin Endocrinol Metab. 2003:88:3379-84.
23. Kobayashi J, Tashiro J, Murano S, Morisaki N, Saito Y. Lipoprotein lipase mass and activity in post-heparin plasma from subjects with intra-abdominal visceral fat accumulation. din Endocrinol (Oxf). 1998;48:515-20.
24. Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis. 1990:10:497-511.
25. Nimmo L, McColl AJ, Rosankiewicz JZ, Richmond W, Elkeles RS. Regulation of hepatic lipase expression in HepG2 cells. Biochem Soc Trans. 1997;25:S689.
26. Thuren T. Hepatic lipase and HDL metabolism. Curr Opin Lipidol 2000;11:277-83.
27. Jansen H, Verhoeven AJ, Weeks L, et al. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vase Biol. 1997;17: 2837-42.
28. Betteridge DJ. Diabetic dyslipidaemia. Eur J Clin Invest. 1999;29(Suppl 2):12-6.
29. Savard R, Deshaies Y, Despres JP, et al. Lipogenesis and lipoprotein lipase in human adipose tissue: reproducibility of measurements and relationships with fat cell size. Can J Physiol Pharmacol. 1984:62:1448-52.
30. Tan KC, Shiu SW, Chu BY. Effects of gender, hepatic lipase gene polymorphism and type 2 diabetes mellitus on hepatic lipase activity in Chinese. Atherosclerosis. 2001:157: 233-9.
31. Kong C, Nimmo L, Elatrozy T, et al. Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in type 2 diabetes. Atherosclerosis. 2001;156:373-8.